Immunotherapy_Submission_Supplementary_Table_22Dec22.docx (55.27 kB)
Download fileReal-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA. Supplementary table
dataset
posted on 2023-02-15, 08:34 authored by Jong Seok Kim, Yajun Emily Zhu, Catherine Elizabeth Muehlenbein, Yimei Han, KayOnda Bayo, Himani AggarwalSupplementary table
